Wall Street's Insights Into Key Metrics Ahead of RadNet (RDNT) Q2 Earnings

Analysts on Wall Street project that RadNet (RDNT) will announce quarterly earnings of $0.17 per share in its forthcoming report, representing an increase of 6.3% year over year. Revenues are projected to reach $488.57 million, increasing 6.3% from the same quarter last year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.Bearing this in mind, let's now explore the average estimates of specific RadNet metrics that are commonly monitored and projected by Wall Street analysts.The consensus estimate for 'Revenue- Imaging Center' stands at $467.90 million. The estimate indicates a year-over-year change of +3.9%.The average prediction of analysts places 'Revenue- Service fee' at $459.02 million. The estimate indicates a change of +8.6% from the prior-year quarter.The combined assessment of analysts suggests that 'Revenue- Digital Health' will likely reach $19.92 million. The estimate points to a change of +26% from the year-ago quarter. View all Key Company Metrics for RadNet here>>> Over the past month, shares of RadNet have returned +0.3% versus the Zacks S&P 500 composite's +0.5% change. Currently, RDNT carries a Zacks Rank #5 (Strong Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report RadNet, Inc. (RDNT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks